Glaxosmithkline | GSK - 营业利润



金融业
股票价格
GBP
资产
GBP 62.87B
现金及等价物
GBP 3.44B
销售成本
GBP 1.88B
流动资产
GBP 17.76B
流动负债
GBP 22.43B
债务
GBP 19.06B
股息收益率
GBP 4.47
EBIT
GBP 2.31B
EBITDA
GBP 2.77B
员工
GBP 69.4K
EPS每股收益
GBP 0.62
股本和储备
GBP 17.42B
销售毛利
GBP 5.75B
债务利息支出
GBP 192.73M
利息收入
GBP 22M
贷款资金
GBP 18.53B
市值
GBP 108.55B
净收入
GBP 1.74B
营业费用
GBP 5.34B
营业利润
GBP 2.29B
普通股股本
GBP 4.05B
PE价格收益
15.09
税前利润
GBP 2.14B
销售收入
GBP 10.09B
销售和管理费用
GBP 2.12B
股票
GBP 6.16B
贸易债权人
GBP 14.34B
应收帐款人
GBP 10.49B


营业利润 更改 日
AbbVie USD 4.73B 1.08B 2026-03
Amgen USD 3.83B 130M 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
Aurora Cannabis CAD -10.03M 25.76M 2026-03
Bausch Health Companies USD 489M 230M 2026-03
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Canopy Growth CAD -27.47M 14.81M 2026-03
Corcept Therapeutics USD -49.6M 54.09M 2026-03
Drreddys Laboratories INR 829M 13.5B 2026-03
Eli Lilly USD 9.78B 792M 2026-03
GlaxoSmithKline GBP 2.29B 856M 2026-03
Glaxosmithkline GBP 2.29B 3.08M 2026-03
J&J USD 6.62B 1.03B 2026-03
Merck USD -1.88B 8.12B 2026-03
Novartis USD 4.24B 171M 2026-03
Pacira USD 4.62M 1.43M 2026-03
Perrigo USD 33.6M 50.8M 2026-03
Pfizer USD 4.99B 340M 2026-03
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 75.49M 7M 2026-03
Roche Holding CHF 9.56B 3.8B 2025-12
Sanofi EUR 1.94B 239M 2026-03
Supernus Pharmaceuticals USD -35.25M 49.07M 2026-03
Takeda JPY -13.62B 182.44B 2026-03
Teva Pharmaceutical Industries USD 758M 271M 2026-03
Zoetis USD 865M 30M 2026-03